Neos Therapeutics (NEOS) PT Lowered to $3 at BMO Capital Aug 12, 2019 08:05AM
Neos Therapeutics (NEOS) PT Lowered to $4 at BMO Capital May 13, 2019 07:49AM
Neos Therapeutics (NEOS) PT Lowered to $8 at BMO Capital Aug 12, 2018 03:57PM
BMO Capital Downgrades Neos Therapeutics (NEOS) to Market Perform Jan 31, 2018 04:25AM
Neos Therapeutics to Participate in Two December Conferences Nov 28, 2017 08:00AM


Jun 20, 2017 07:37AM Neos Therapeutics (NEOS): ADHD Approval Just In Time For Back To School - BMO
Mar 10, 2017 10:43AM BMO Capital Reiterates Outperform Rating and $15 PT on Neos Therapeutics (NEOS); 'Steady Growth in Adzenys XR-ODT'
Feb 3, 2017 08:30AM Neos Therapeutics Announces Pricing of Underwritten Public Offering of $25.0 Million of Common Stock
Feb 2, 2017 04:05PM Neos Therapeutics (NEOS) to Offer Common Stock
Feb 2, 2017 04:01PM Neos Therapeutics Announces Proposed Offering of Common Stock
Sep 20, 2016 09:44AM Neos Therapeutics (NEOS): Thoughts After Management Meetings - BMO
Jun 28, 2016 04:48PM BMO Capital Starts Neos Therapeutics (NEOS) at Outperform
Aug 17, 2015 07:39AM BMO Capital Starts Neos Therapeutics (NEOS) at Outperform
Jul 28, 2015 04:01PM Neos Therapeutics Announces Closing of Initial Public Offering and Exercise of Underwriters’ Over-Allotment Option
Jul 23, 2015 10:29AM Neos Therapeutics (NEOS) IPO Opens 21% Higher
Jul 23, 2015 09:27AM Neos Therapeutics (NEOS) Prices 4.8M Common Stock IPO at $15/Share, at Middle of Range
Jul 23, 2015 07:00AM Neos Therapeutics Announces Pricing of Initial Public Offering